Howard McLeod

Howard McLeod is a renowned pharmacogenomics researcher and pharmacist. He is best known for his significant contributions to the field of personalized medicine, particularly in the area of cancer treatment.

Early Life and Education[edit | edit source]

Howard McLeod was born and raised in Canada. He completed his undergraduate studies in pharmacy at the University of Manitoba. He then pursued his postgraduate studies in the United States, earning a PharmD from the University of Texas.

Career[edit | edit source]

McLeod has held numerous prestigious positions throughout his career. He served as the Medical Director at the Moffitt Cancer Center's Personalized Medicine Institute. He also held the position of Chair for the Department of Individualized Cancer Management and was a Senior Member of the Department of Cancer Epidemiology at the same institution.

In addition to his roles at the Moffitt Cancer Center, McLeod has also served as a Professor at the University of North Carolina's Eshelman School of Pharmacy. His research at the university primarily focuses on how genetic variation in a patient can affect their response to medications, particularly in the context of cancer treatment.

Contributions to Pharmacogenomics[edit | edit source]

McLeod's work in pharmacogenomics has been instrumental in advancing the field of personalized medicine. His research has helped to identify genetic markers that can predict a patient's response to certain cancer treatments. This has the potential to greatly improve patient outcomes by allowing for more targeted and effective treatment plans.

Awards and Recognition[edit | edit source]

Over the course of his career, McLeod has received numerous awards and recognition for his work. This includes the American Society of Clinical Oncology's Translational Research Professorship and the Thomson Reuters' "World’s Most Influential Scientific Minds" award.